Teva CEO responds to 25% share price fall
Teva CEO Richard Francis said that he had not expected such a harsh reaction from the market but he sees a positive side to ...
Pharm Exec12d
The Teva Turnaround: Steering a Company Comeback
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...
GlobalData on MSN6d
New CEOs to join Merck KGaA’s executive board
E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing ...
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...
Le Lézard8d
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. ("PharmaEssentia") and AOP Orphan ...
pharmaphorum2d
Pfizer confirms $160bn reverse takeover of Allergan
If and when approved by shareholders and regulators, the combined company will retain Pfizer's global operational headquarters ... will create a leading global pharmaceutical company with the ...
New Jersey Business11d
BioNJ Elects Board Officers and Trustees
Life sciences trade association BioNJ has announced the election of its 2025 Officers and Board Members in concert with BioNJ ...